Doctors & patients are saying about 'A-Fib.com'...

"A-Fib.com is a great web site for patients, that is unequaled by anything else out there."

Dr. Douglas L. Packer, MD, FHRS, Mayo Clinic, Rochester, MN

"Jill and I put you and your work in our prayers every night. What you do to help people through this [A-Fib] process is really incredible."

Jill and Steve Douglas, East Troy, WI

“I really appreciate all the information on your website as it allows me to be a better informed patient and to know what questions to ask my EP.

Faye Spencer, Boise, ID, April 2017

“I think your site has helped a lot of patients.”

Dr. Hugh G. Calkins, MD Johns Hopkins,
Baltimore, MD

Doctors & patients are saying about 'Beat Your A-Fib'...

"If I had [your book] 10 years ago, it would have saved me 8 years of hell.”

Roy Salmon, Patient, A-Fib Free,
Adelaide, Australia

"This book is incredibly complete and easy-to-understand for anybody. I certainly recommend it for patients who want to know more about atrial fibrillation than what they will learn from doctors...."

Pierre Jaïs, M.D. Professor of Cardiology, Haut-Lévêque Hospital, Bordeaux, France

"Dear Steve, I saw a patient this morning with your book [in hand] and highlights throughout. She loves it and finds it very useful to help her in dealing with atrial fibrillation."

Dr. Wilber Su,
Cavanaugh Heart Center, Phoenix, AZ

"...masterful. You managed to combine an encyclopedic compilation of information with the simplicity of presentation that enhances the delivery of the information to the reader. This is not an easy thing to do, but you have been very, very successful at it."

Ira David Levin, heart patient,
Rome, Italy

"Within the pages of Beat Your A-Fib, Dr. Steve Ryan, PhD, provides a comprehensive guide for persons seeking to find a cure for their Atrial Fibrillation."

Walter Kerwin, MD, Cedars-Sinai Medical Center, Los Angeles, CA

Revised Article: Warfarin vs. Pradaxa and the Other New Anticoagulants (NOACs)

Published June 29, 2018

In May 2018, the FDA approval the reversal agent, Andexxa, for the NOACs Xarelto (rivaroxaban) and Eliquis (apixaban). Pradaxa (dabigatran) has had the reversal agent, Praxbind, since 2015.

This news sent us searching A-Fib.com for NOAC articles that might need to be updated. One such article is Warfarin vs. Pradaxa and the Other New Anticoagulants.

In the end we revised the entire article, which was originally written in 2015 with periodic revisions in 2016, 2017 and earlier this year.

Stay Informed. Know Your Choices.

Warfarin vs. Pradaxa and the Other New Anticoagulants is a good review of your anticoagulant choices, the risks and benefits of each, costs, and recent research on the side-effects of long time use of these blood thinners.

Partner with your doctor: Whether or not to go on an anticoagulant, and which one, is one of the most difficult decisions you and your doctor have to make. Stay up-to-date. Then you can partner with your doctor on a plan that meets your treatment goals.

Don’t forget: Your anticoagulant treatment choice may change over time (with lifestyle changes, interaction with other medications, getting older, etc). Go to: Warfarin vs. Pradaxa and the Other New Anticoagulants.

Educate yourself.
Become your own best patient advocate.